Evidence map›Paper›PMID 40597015›Full record

ArticleBMC cancer2025

Cross-cultural adaptation and validation of the Chinese version of the taste and smell survey for cancer patients.

Haixin Liang, Qing Yang, Li Yin, Huarong Pang, Enmei Jiu, Bin Li, Lei Qin

Abstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haixin LiangDepartment of Comprehensive Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China.
Qing YangDepartment of Nursing, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China.
Li YinRadiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Head and Neck Radiotherapy Department 3, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China.
Huarong PangDepartment of Comprehensive Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China.
Enmei JiuDepartment of Comprehensive Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China.
Bin LiDepartment of Comprehensive Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China.
Lei QinHospital Administration Office, Cheng Fei Hospital, Chengdu, China. helloqinl@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo translate and culturally adapt the Taste and Smell Survey (TSS) in Chinese for cancer patients and assess its reliability and validity, and to provide a reference for clinical professionals to evaluate taste and smell alterations (TSAs) in cancer patients.

methodsWith authorization from the original authors, the survey was translated and back-translated following the standard procedure to generate the Chinese version of the TSS. 271 patients were enrolled from a tertiary hospital in China under treatment between January 2023 and February 2024 using a convenience sampling method for reliability and validity testing of the translated scale.

resultsThe overall Cronbach's α for the Chinese version of the TSS was 0.872. Cronbach's α for individual items ranged from 0.844 to 0.897. Content Validity Indices (I-CVI) for individual items ranged from 0.833 to 1.000, and the Average Scale-level Content Validity Index (S-CVI/Ave) was 0.972. All indices calculated in the Confirmatory Factor Analysis (CFA) were presented as follows: χ²/df = 3.446, the Goodness-of-fit Index (GFI) = 0.902, the Comparative Fit Index (CFI) = 0.946, the Incremental Fit Index (IFI) = 0.946, the Tucker‒Lewis Index (TLI) = 0.930, the Root Mean Square Residual (RMR) = 0.054, and the Root Mean Square Error of Approximation (RMSEA) = 0.095. All of the above results indicated good validity and reliability of the Chinese version of the TSS.

conclusionThe study has confirmed that the Chinese version of the TSS is a concise and effective tool that is easy to administer and demonstrates strong scientific quality, reliability, validity, and feasibility. It is expected to help clinical professionals provide evidence-based interventions related to TSAs in cancer patients undergoing treatments in the Chinese cultural context.

Indexed as

NeoplasmsOlfaction DisordersSmellTasteTaste DisordersAdultAgedChinaCross-Cultural ComparisonFemaleHumansMaleMiddle AgedPsychometricsReproducibility of ResultsSurveys and QuestionnairesScale developmentSmellSurveyTasteValidation

Identifiers

PMID40597015
PMCPMC12211181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.